TB advocates

Advocates call on pharma companies to improve access to MDR-TB drugs

TB advocates urge Janssen and Otsuka to improve the affordability and availability of bedaquiline and delamanid.

Read More →

Activists urge Indian government to fix deadly gaps in its TB response

Activists take over a session at the Union conference in Liverpool bringing awareness and attention to a number of broken promises by the Indian government to address a growing drug-resistant TB epidemic that burdens the nation.

Read More →

Advocates appeal to the Union Board to host Union World Conferences on Lung Health in high TB burden countries

TB advocates ask that, at a minimum, every second Union World Conference be held in a country with a high burden of TB and/or lung disease.

Read More →

Advocates call for the Ministry of Health in Cote d’Ivoire to adopt new TB test

TB advocates urge the Ministry of Health in Cote d’Ivoire to introduce a new, simple, and rapid TB test, TB LAM, which detects TB antigens in urine, and is an important tool for detecting TB in certain populations living with HIV.

Read More →

Advocates commend Johns Hopkins University for pursuing a public health driven path for sutezolid’s development

TB advocates congratulate Johns Hopkins University’s decision to enter negotiations with the Medicines Patent Pool regarding the licensing of worldwide non-exclusive rights to sutezolid.

Read More →

Advocates call for WHO to update Delamanid Guidance to include children

On World TB Day, and in light of new evidence of safety in children, advocates called on the World Health Organization to update its 2014 guidance on delamanid to include children.

Read More →

Non-governmental organizations and civil society groups advocate for TB in U.S. government FY2017 appropriations

As planning for U.S. government spending in fiscal year (FY) 2017 is underway, advocates from U.S.-based NGOs and civil society groups have appealed to legislators to prioritize TB.

Read More →

Urgent need to make linezolid available in South Africa at affordable price

TB advocates urge pharmaceutical companies to register their respective linezolid products in South Africa and make them available at an affordable price.

Read More →

Urgent need to register quality generic versions of linezolid in South Africa

TB advocates request that the South African Medicines Control Council prioritize registration of quality-assured versions of generic linezolid for the treatment of drug-resistant TB.

Read More →

Urgent need to scale up access to new treatment options for MDR-TB in the Philippines

Given the urgent need to address the MDR-TB epidemic in the Philippines, advocates urge for rapid delivery of the new treatment options to people with MDR-TB.

Read More →

Page 2 of 3 · Total posts: 10

←First 1 2 3 Last→